Trevi Therapeutics Inc
NASDAQ:TRVI

Watchlist Manager
Trevi Therapeutics Inc Logo
Trevi Therapeutics Inc
NASDAQ:TRVI
Watchlist
Price: 12.56 USD -2.03%
Market Cap: 1.6B USD

Wall Street
Price Targets

TRVI Price Targets Summary
Trevi Therapeutics Inc

Wall Street analysts forecast TRVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TRVI is 21.5 USD with a low forecast of 16.16 USD and a high forecast of 28.35 USD.

Lowest
Price Target
16.16 USD
29% Upside
Average
Price Target
21.5 USD
71% Upside
Highest
Price Target
28.35 USD
126% Upside
Trevi Therapeutics Inc Competitors:
Price Targets
ROG
Roche Holding AG
4% Downside
LUPIN
Lupin Ltd
10% Upside
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
7% Upside
4568
Daiichi Sankyo Co Ltd
68% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
24% Upside
4530
Hisamitsu Pharmaceutical Co Inc
1% Downside
DHG
Dhg Pharmaceutical Joint-Stock Co
17% Upside
000423
Dong-E-E-Jiao Co Ltd
58% Upside

Revenue
Forecast

Revenue Estimate
Trevi Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Trevi Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Trevi Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-71%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TRVI's stock price target?
Price Target
21.5 USD

According to Wall Street analysts, the average 1-year price target for TRVI is 21.5 USD with a low forecast of 16.16 USD and a high forecast of 28.35 USD.

Back to Top